Menu
Global
简体中文
繁体中文
English
Home
About Us
Company Introduction
Development History
Leadership Team
Honor and Qualification
Industry Chain
Corporate Culture
R & D
Therapeutic Area
Technology Platform
Innovative Pipeline
Partnering
Products
Oncology
Digestive
NASH
Investor
Stock Information
Announcements and Circulars
Financial Report
Corporate governance
Investor Calendar
Company Information
Prospectus
Investor Relations
News
Contact Us
Address
Contact Information
Adverse drug reaction report
Join XZenith
Our Culture
Careers
Benefit
Talent Development
Employee style
News center
Enterprise dynamics
Corporate News
All
2019
2020
2021
2022
2023
2024
2025
09-03
2026
Further Expanding Overseas Footprint | X...
Recently, Xuanzhu Biopharma Technology Co., Ltd. [hereinafter referred to as: Xuanzhu Biopharma] and...
08-03
2026
Honor | Xuanzhu Biopharma Wins the 2026
Recently, the 5th International Green Zero-Carbon Festival and the 2026 ESG Leaders Summit were held...
07-27
2026
Honor | Xuanzhu Biopharma Selected for t...
Recently, the 2026 Industry King Global Intellectual Property Ecosystem Conference, hosted by IPR Da...
06-30
2026
Major breakthrough! The domestically dev...
Recently, Xuanzhu Biotech achieved a significant milestone in its R&D efforts: the marketing reg...
06-26
2026
Honors | Xuanzhu Biotech Selected as one
Recently, the "2026 China Top 100 Pharmaceutical Innovation Enterprises" list was official...
<
1
2
3
4
>
Home
About Us
+
Company Introduction
Development History
Leadership Team
Honor and Qualification
Industry Chain
Corporate Culture
R & D
+
Therapeutic Area
Technology Platform
Innovative Pipeline
Partnering
Products
+
Oncology
Digestive
NASH
Investor
+
Stock Information
Announcements and Circulars
Financial Report
Corporate governance
Investor Calendar
Company Information
Prospectus
Investor Relations
News
+
Contact Us
+
Address
Contact Information
Adverse drug reaction report
Join XZenith
+
Our Culture
Careers
Benefit
Talent Development
Employee style